185 related articles for article (PubMed ID: 20449800)
1. CCR2-64I is a risk factor for development of bladder cancer.
Narter KF; Agachan B; Sozen S; Cincin ZB; Isbir T
Genet Mol Res; 2010 Apr; 9(2):685-92. PubMed ID: 20449800
[TBL] [Abstract][Full Text] [Related]
2. Association of CCL2 and CCR2 gene variants with endometrial cancer in Turkish women.
Attar R; Agachan B; Kuran SB; Cacina C; Sozen S; Yurdum LM; Attar E; Isbir T
In Vivo; 2010; 24(2):243-8. PubMed ID: 20364004
[TBL] [Abstract][Full Text] [Related]
3. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L
Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
[TBL] [Abstract][Full Text] [Related]
4. MCP-1 and CCR2 gene variants in oral squamous cell carcinoma.
Bektas-Kayhan K; Unur M; Boy-Metin Z; Cakmakoglu B
Oral Dis; 2012 Jan; 18(1):55-9. PubMed ID: 21883707
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma.
Yeh CB; Tsai HT; Chen YC; Kuo WH; Chen TY; Hsieh YH; Chou MC; Yang SF
J Surg Oncol; 2010 Sep; 102(3):264-70. PubMed ID: 20740585
[TBL] [Abstract][Full Text] [Related]
6. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
[TBL] [Abstract][Full Text] [Related]
7. Association of MCP-1 and CCR2 polymorphisms with the risk of late acute rejection after renal transplantation in Korean patients.
Kang SW; Park SJ; Kim YW; Kim YH; Sohn HS; Yoon YC; Joo H; Jeong KH; Lee SH; Lee TW; Ihm CG
Int J Immunogenet; 2008 Feb; 35(1):25-31. PubMed ID: 18186797
[TBL] [Abstract][Full Text] [Related]
8. The association of monocyte chemotactic protein-1 and CC chemokine receptor 2 gene variants with chronic obstructive pulmonary disease.
Bai J; Song H; Cai C; Zhang M; Xu S; Tan J
DNA Cell Biol; 2012 Jun; 31(6):1058-63. PubMed ID: 22276574
[TBL] [Abstract][Full Text] [Related]
9. Impact of chemokine receptor CCR2 and CCR5 gene polymorphism on allograft outcome in North Indian renal transplant recipients.
Singh R; Kapoor R; Srivastava A; Mittal RD
Scand J Immunol; 2009 Jan; 69(1):51-6. PubMed ID: 19037908
[TBL] [Abstract][Full Text] [Related]
10. Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma.
Liu GX; Zhang X; Li S; Koiiche RD; Sindsceii JH; Song H
Tumour Biol; 2013 Oct; 34(5):2741-6. PubMed ID: 23657965
[TBL] [Abstract][Full Text] [Related]
11. Association of the MCP-1 -2518 A/G polymorphism and no association of its receptor CCR2 -64 V/I polymorphism with lupus nephritis.
Malafronte P; Vieira JM; Pereira AC; Krieger JE; Barros RT; Woronik V
J Rheumatol; 2010 Apr; 37(4):776-82. PubMed ID: 20231199
[TBL] [Abstract][Full Text] [Related]
12. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
[TBL] [Abstract][Full Text] [Related]
13. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.
Gharagozloo M; Doroudchi M; Farjadian S; Pezeshki AM; Ghaderi A
Immunol Lett; 2005 Jan; 96(2):277-81. PubMed ID: 15585333
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study.
Lin J; Spitz MR; Wang Y; Schabath MB; Gorlov IP; Hernandez LM; Pillow PC; Grossman HB; Wu X
Carcinogenesis; 2004 Sep; 25(9):1639-47. PubMed ID: 15117811
[TBL] [Abstract][Full Text] [Related]
15. CCR2-64I polymorphism is associated with Non-Small Cell Lung Cancer in Tunisian patients.
Rafrafi A; Kaabachi S; Kaabachi W; Chahed B; Amor AB; Mbarik M; Charrad R; Salah MO; Hamzaoui K; Sassi FH
Hum Immunol; 2015 May; 76(5):348-54. PubMed ID: 25797207
[TBL] [Abstract][Full Text] [Related]
16. Allograft renal rejection and chemokine polymorphism.
Gorgi Y; Sfar I; Jendoubi-Ayed S; Makhlouf M; Rhomdhane TB; Bardi R; Aouadi H; Abdallah TB; Abderrahim E; Ayed K
Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):18-23. PubMed ID: 21196609
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation at the CCR5/CCR2 gene cluster and risk of psoriasis and psoriatic arthritis.
Soto-Sánchez J; Santos-Juanes J; Coto-Segura P; Coto E; Díaz M; Rodríguez I; Alvarez V
Cytokine; 2010 May; 50(2):114-6. PubMed ID: 20153665
[TBL] [Abstract][Full Text] [Related]
18. Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer.
Kucukgergin C; Isman FK; Cakmakoglu B; Sanli O; Seckin S
DNA Cell Biol; 2012 Aug; 31(8):1418-24. PubMed ID: 22612293
[TBL] [Abstract][Full Text] [Related]
19. MCP-1 and CCR2 gene polymorphisms in Czech patients with allergic disorders.
Holla LI; Mrazek F; Petrek M
Int J Immunogenet; 2009 Feb; 36(1):69-72. PubMed ID: 19055601
[TBL] [Abstract][Full Text] [Related]
20. CCR2-64I polymorphism and CCR5Delta32 deletion in patients with Alzheimer's disease.
Galimberti D; Fenoglio C; Lovati C; Gatti A; Guidi I; Venturelli E; Cutter GR; Mariani C; Forloni G; Pettenati C; Baron P; Conti G; Bresolin N; Scarpini E
J Neurol Sci; 2004 Oct; 225(1-2):79-83. PubMed ID: 15465089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
